Compounds > l 692429
Page last updated: 2024-09-03

l 692429 and Obesity

l 692429 has been researched along with Obesity in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gertz, BJ; Hartman, ML; Kirk, SE; Krupa, DA; Pezzoli, SS; Schneider, SH; Seibold, JR; Thorner, MO; Wittreich, JM1
Svensson, J1

Reviews

1 review(s) available for l 692429 and Obesity

ArticleYear
Growth hormone secretagogues as therapeutic agents.
    Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society, 1999, Volume: 9 Suppl A

    Topics: Adult; Aged; Benzazepines; Child; Growth Disorders; Human Growth Hormone; Humans; Indoles; Male; Obesity; Oligopeptides; Spiro Compounds; Tetrazoles

1999

Trials

1 trial(s) available for l 692429 and Obesity

ArticleYear
Effect of obesity and feeding on the growth hormone (GH) response to the GH secretagogue L-692,429 in young men.
    The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:4

    Topics: Adult; Benzazepines; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Eating; Human Growth Hormone; Humans; Male; Obesity; Reference Values; Tetrazoles

1997